인쇄하기
취소
|
Hanmi Pharm(CEO Gwan-Sun Lee) announced it recorded KRW 882.724 billion sales decreased by 33% and made KRW 26.771 billion operating income and KRW 30.299 net profits, significantly decreased by 87.3% and 81.30% respectively, in 2016.
The company explained the last year’s sales was decreased since the top effect and technology agreement was applied after the KRW 512.5 technology profits in the...